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Abstract
Background: The ability to capture and sequence large contiguous DNA fragments represents a significant
advancement towards the comprehensive characterization of complex genomic regions. While emerging
sequencing platforms are capable of producing several kilobases-long reads, the fragment sizes generated by
current DNA target enrichment technologies remain a limiting factor, producing DNA fragments generally shorter
than 1 kbp. The DNA enrichment methodology described herein, Region-Specific Extraction (RSE), produces DNA
segments in excess of 20 kbp in length. Coupling this enrichment method to appropriate sequencing platforms will
significantly enhance the ability to generate complete and accurate sequence characterization of any genomic
region without the need for reference-based assembly.
Results: RSE is a long-range DNA target capture methodology that relies on the specific hybridization of short
(20-25 base) oligonucleotide primers to selected sequence motifs within the DNA target region. These capture
primers are then enzymatically extended on the 3’-end, incorporating biotinylated nucleotides into the DNA.
Streptavidin-coated beads are subsequently used to pull-down the original, long DNA template molecules via the
newly synthesized, biotinylated DNA that is bound to them. We demonstrate the accuracy, simplicity and utility of
the RSE method by capturing and sequencing a 4 Mbp stretch of the major histocompatibility complex (MHC). Our
results show an average depth of coverage of 164X for the entire MHC. This depth of coverage contributes
significantly to a 99.94 % total coverage of the targeted region and to an accuracy that is over 99.99 %.
Conclusions: RSE represents a cost-effective target enrichment method capable of producing sequencing
templates in excess of 20 kbp in length. The utility of our method has been proven to generate superior coverage
across the MHC as compared to other commercially available methodologies, with the added advantage of
producing longer sequencing templates amenable to DNA sequencing on recently developed platforms. Although
our demonstration of the method does not utilize these DNA sequencing platforms directly, our results indicate
that the capture of long DNA fragments produce superior coverage of the targeted region.
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Background
Next-Generation Sequencing (NGS) technology has for-
ever transformed the field of genetics, enabling large-
scale, high throughput genetic studies for a variety of
research and diagnostic applications. While economic-
ally sequencing entire genomes remains an important
goal of NGS, many research and diagnostic applications
are best achieved through targeted DNA sequencing of
specific genomic loci. Targeted DNA sequencing is ad-
vantageous not only because it is more cost effective, as
it facilitates higher sample throughput than whole gen-
ome sequencing, but also because it improves accuracy
by optimizing the read depth coverage and by reducing
the complexity of the DNA to be sequenced.
Several methods have been developed for the targeted
enrichment of genomic DNA [1–4] for a variety of clin-
ical and research applications [5–11]. They are typically
based upon a multiplexed PCR amplification reaction
[12], DNA hybridization to a capture oligonucleotide
(either on an array or in solution) [13–15] or DNA
capture via molecular inversion probe circularization
[16, 17]. Regardless of the method employed, all of these
DNA enrichment methods rely heavily on fragmentation
of genomic DNA prior to amplification, resulting in
relatively short (less than 1000 base-pair) sequencing
templates. As a result, existing methods for genomic
partitioning remain a severely limiting factor for com-
prehensively characterizing complex genomic loci because
they cannot provide the larger size fragments that are
required to successfully span confounding sequence ele-
ments, such as extended repeats, or resolve sections of
unknown or unexpected sequence that have been inserted
or rearranged within the targeted region [18, 19].
Importantly, such large DNA templates can now be
utilized by the newer, “third generation” sequencing
platforms which are capable of producing significantly
larger read lengths [20–22] and sequencing through
traditionally difficult sequence templates with high GC
content [23]. The longer read lengths produced by these
platforms have been shown to be highly advantageous in
characterizing structural variants, haplotype phasing
within complex genomic loci and de novo genome
assembly [22, 24–26].
Our DNA enrichment method, Region Specific Extrac-
tion (RSE), addresses this unmet need by capturing long
DNA fragments of ≈ 20 kbp in length. RSE utilizes a
single primer extension step for capture in which sta-
ndard oligonucleotides (≈20 bases in length) hybridize to
highly specific sequence motifs within the targeted
region(s) and are enzymatically extended to include bio-
tinylated nucleotides within the nascent DNA strand.
The targeted genomic DNA segments are then pulled
down using streptavidin-coated magnetic particles,
which bind to the newly synthesized biotinylated DNA
sections. These biotinylated portions represent a small
percentage of the overall extracted DNA and do not
pose a challenge to the efficiency of library preparation
and sequencing. The captured segments of the original
genomic DNA template, which extend far into both
directions from any single point where a capture primer
has been hybridized, are then typically amplified by
whole genome amplification and processed by standard
NGS sequencing protocols (Fig. 1).
A specific program (Antholigo; see “Methods”) we
developed for the primer design can be instructed to
position the primers at variable distances from their
nearest neighbors. If desired, this distance can be 8-10
kbp or greater in order to minimize the number of
primers used, while providing for optimal coverage of
the targeted region. RSE is simple to use and requires no
fragmentation of the genomic sample prior to capture,
as other enrichment technologies do. Although the
typical size of captured fragments in this study was
about 20 kbp, the same principle has been used to
extract significantly larger segments depending on DNA
quality and the method used for its extraction [27].
Here we demonstrate the utility of RSE for the
targeted sequencing of the most complex region of the
human genome, the major histocompatibility complex
(MHC; HG19 coordinates chr6:29618227-33618227) on
the short arm of chromosome 6. The MHC is known to
be the most gene-dense region of the human genome,
with many transcribed genes playing an important role
in innate and adaptive immune processes [28]. Conse-
quently, numerous loci throughout the MHC have been
associated with immune-mediated diseases [29–32]. The
MHC contains dozens of highly polymorphic genes and
large regions of duplication and repetitive elements [28].
Interestingly, despite its significance, there are only two
completely characterized MHC haplotypes from two
homozygous B cell lines namely PGF (the reference
sequence for the MHC in the reference human genome)
and COX [33–36]. The same region of the MHC and of
the same cell line PGF has been targeted by other
capture technologies [15] and offers a unique opportun-
ity for comparisons that demonstrate the advantages of
RSE. Eventually this technology can contribute greatly to
the comprehensive characterization of such difficult
regions around the genome by providing both accurate
sequencing and description of structural variations in-
cluding deletions, insertions and duplications.
Results and discussion
Capture efficiency
For a normal distribution of genomic fragment sizes, the
highest capture efficiency is observed closest to the RSE pri-
mer hybridization site, with decreasing template copy num-
bers observed further away from the primer hybridization
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site (see Fig. 2a for schematic representation). We de-
termined the amount of targeted material obtained as
a function of distance from the primer hybridization
site in order to determine the optimal spacing be-
tween designed primers so as to maximize capture ef-
ficiency for sequencing and prevent gaps in coverage
between adjacent primer hybridization sites, while at the
same time, design and synthesize a minimum number
of primers.
The optimal spacing of capture primers depends in
part on the particular DNA extraction method that was
used to prepare the DNA from blood, tissue or cells:
Fig. 1 Principle of RSE. a During the first step of RSE, the genomic template DNA (light blue) briefly gets denatured to allow capture primers (red)
to hybridize. b The bound primers are enzymatically extended with biotinylated nucleotides. The extended portions of the primers, shown in
green, form the “handle” to which streptavidin-coated magnetic beads bind. During this process many biotins of the same primer/target DNA
complex are bound to streptavidin binding sites on the same bead, thereby forming a topological linkage that firmly locks even very long DNA
segments extending in both directions from the capture point onto the surface of the magnetic bead. The primer/target DNA complex is then
magnetically purified and released from the bead surface by heat. (The drawing is not to scale: the magnetic beads are approximately an order of
magnitude larger than illustrated here)
Fig. 2 Effects of RSE capture primer spacing on target enrichment. a Schematic representation of the distribution of captured genomic
DNA copy number obtained around the primer hybridization site, indicated with a red triangle, as measured by qPCRs, placed at
increasing distances from the primer hybridization site and shown with black inverted triangles. Gray bars indicate captured random DNA
fragments. b qPCR results for RSE extracted material at seven non-contiguous genomic regions, plotted as the copy number ratio of
targeted sites (indicated as diamonds) to a common non-targeted region (beta actin). The amount of targeted vs. off-target material
decreases within about 10 kbp of the RSE extraction site
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The larger the fragments of DNA generated during
extraction, the larger the spacing of the primers can be.
To study the dependence of capture efficiency at variable
distances from the point of primer hybridization, we
designed qPCR assays at varying distances from single
RSE primers at multiple genomic regions: CLEC16A,
EGFR, BRCA2, KCNE1, NOS3, KCNJ2 and CETP
(Fig. 2b). We purposely selected unrelated genomic
targets to avoid any potential capture bias due to local
sequence content and likewise controlled for reliable
qPCR amplification at the selected positions. For the
DNA used in this study (human genomic DNA extracted
by magnetic particle-based isolation on the BioRobot
EZ1 (Qiagen), stored frozen in EB and approximately 6-
24 months old), qPCR probes located within 1 kbp of a
single RSE capture primer generated target to non-target
ratios of greater than ≈ 35:1, and primers 2–4 kbp distant
produced target to non-target ratios of ≈ 20:1 or greater
(Fig. 2b). At a distance of approximately 8-9 kbp from a
capture primer, the target to non-target ratio dropped
to ≈ 10:1. Estimating this trend beyond 10 kbp, we pro-
jected that beyond approximately 25 kbp there will be
little to no difference between targeted and non-targeted
material for the DNA used here.
CGH – Determination of effective primer spacing
To further confirm that the RSE primers are placed at
optimal intervals in order to secure continuity of cover-
age across the targeted region, we utilized a comparative
hybridization array. Since some RSE primers are more
effective than others (presumably due to regional se-
quence differences), we investigated the nominal primer
spacing necessary to maintain sufficient enrichment for
reliable sequencing across a large region (Fig. 3a). Four
gene regions (EGFR, BRCA2, KCNJ2 and CLEC16A)
that had previously been analyzed on a custom Agilent
comparative genomic hybridization (CGH) chip were
selected for extraction by RSE. For each region, between
9 and 16 RSE primers were designed with an average
spacing of ≈ 16 kbp (Fig. 3b). The captured genomic
DNA was then fluorescently labeled with Cy3/Cy5 and
hybridized to the arrays.
As seen in Fig. 3c, the hybridization signal (Log2Score)
at the mid-point between RSE primers decreases rapidly
with increasing spacing. As predicted by the qPCR data
(Fig. 2b), the array results suggest that primer spacing
intervals greater than ≈ 25 kbp produce no net increase
in the amount of targeted material retrieved per capture
primer. For the purpose of defining sufficient enrich-
ment for sequencing, the results suggest that primer
spacing of <10 kbp is required to avoid dropout of target
template due to any capture efficiency differences that
may occur between primers.
RSE primer design and MHC capture
The RSE capture method was tested and evaluated on the
human MHC because the MHC represents an important
and highly complex genomic region that challenges the
Fig. 3 Effects of RSE capture primer spacing on capture effectiveness. a 46 RSE primers were designed to capture ≈ 700 kbp of genomic
sequence for four gene regions. b To examine the effect of RSE primer spacing on capture efficiency, we assumed that the midpoint between
the RSE primers would produce the least amount of signal on the array. Each midpoint in the bins shown above was averaged across 20 array
primers to account for array probe capture variability. The distance between RSE primers and the averaged array value is presented. c The
distances between RSE primers were segregated into bins to show the collective effect of similar RSE primer spacing. As seen in the graph,
capture of the material as used here at the midpoint between primers drops rapidly beyond ≈ 15 kbp with little to no capture evident at 25 kbp
or greater for the type of genomic DNA used in this study (average length ≈ 20 kbp)
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sequencing enhancement abilities of RSE in a “worst case”
scenario. For validation, the homozygous cell line PGF
was chosen because a majority of the MHC region within
the human reference sequence is based exclusively on the
PGF haplotype. A stable and well-characterized reference
genome is critical for detecting variant calling errors
caused by potential sequence alignment problems, asses-
sing any observed gaps in read coverage and a comparison
with existing DNA capture methodologies, which were
also evaluated on the MHC [15].
Based upon the qPCR and array CGH results, we
designed RSE primers to capture the 4Mbp of the MHC
(HG 19 coordinates chr6-29618227-33618227) of the
homozygous cell line PGF. The primers were designed
based on the reference MHC sequence of the reference
genome (HG19). Using in-house developed software
(antholigo.chop.edu), 500 RSE primers were designed
at ≈ 8 kbp intervals of across the MHC (Additional file 1:
Table S1) with an average melting temperature of 58 °C
and a target GC content of 50 % (+/-10 %). The primers
are designed with similar biophysical characteristics that
optimize their performance in the capture reaction,
which requires the hybridization of oligonucleotides to
genomic DNA.
Sequencing of the MHC
The RSE extracted material was then sequenced using
125b paired-end reads on an Illumina GAIIx. Raw data
(fastq) files have been made publicly available and are
accessible through the NCBI SRA website (SRA acces-
sion: SRP075425). Out of 154,822,132 reads, 134,514,112
remained after trimming for quality. Of 67,257,141 reads
that mapped to the entire human genome, a total of
6,951,692 reads mapped to the targeted MHC region
(Table 1). It therefore derives that about 10 % of the
reads were mapped to the MHC, while 90 % were
mapped to the rest of the entire genome. The depth of
coverage of the targeted MHC region was, on average,
very high (164×) compared to the average coverage of
non-targeted material (2×) (Table 1). So despite the fact
that only 10 % of the reads were mapped to the MHC,
the depth of coverage (164×) across the MHC was
significantly higher than that across the rest of the
genome (2×). Importantly, high depth of coverage was
maintained for a majority of the targeted region with
98.56 % of all MHC bases covered at 20× or greater and
90.68 % at 50× coverage or greater, including the known
homologous and highly repetitive sections of the MHC
(Fig. 4). Since more than half of all bases within the
MHC (52.68 %) are repetitive elements, we also evalu-
ated the sequencing results within stretches of unique
sequences, which was shown to have coverage depth in
excess of 173× (Table 1).
To assess the relationship between the enrichment
efficiency as evaluated by qPCR and the final sequencing
data after sequencing and assembly, we evaluated the
relationship of the absolute copy number obtained from
the enrichment process to the sequence coverage. As
seen in Fig. 5a, coverage was consistent across the entire
MHC region with 99.937 % of the 4 million targeted
bases being called. The absolute enrichment was verified
by quantitative PCR at five sites (randomly chosen)
across the MHC (Fig. 5a). Each qPCR assay site (See
Additional file 1: Table S2 for a list of primers and
probes) was tested for copy number both, before and
after whole genome amplification, of the enriched mater-
ial and compared to the sequencing coverage obtained
directly at the position of the qPCR probe. Figure 5b
displays three of the qPCR sites expanded, +/- 25 kbp
on either side of the primer to show sequencing cover-
age at the respective qPCR primer positions.
As seen in Table 2, there is good correlation (0.94/
R2 ≈ 88 %) between the qPCR results for non-amplified
RSE extracted material and whole genome amplified
material, with even greater correlation between WGA
material and sequencing coverage depth at the qPCR site
(0.97/R2 ≈ 94 %). This demonstrates that amplification
procedures used during NGS library generation do not
lead to substantial imbalances between different regions
and that sequencing coverage approximates the amount
of extracted material obtained through RSE. An overall
evaluation of targeted enrichment efficiency based upon
Table 1 Sequencing results
Targeted Region (bp) 4,000,002 Targeted Bases Called 3,997,493 Depth >1 99.937 %
Unique Bases (bp) 1,895,669 Unique Bases Called 1,891,678 Depth >1 99.789 %
% of Repeat Sequences 52.68
% of Unique Sequences 47.39
Total # of Reads Mapped to Whole Genome 67,257,141
Total # of Mapped Reads to Targeted Region 6,951,692
Average Depth of Coverage for Entire Genome (Non-Targeted) 2
Average Depth of Coverage for Entire Targeted Region 164
Average Depth of Coverage for Unique Sequence in Targeted Region 173
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sequencing results is an enrichment factor of 82.7 fold for
the entire MHC (see in “Methods-Enrichment Determin-
ation” for the exact calculations) or in other words the
average depth of coverage for the MHC, which was 164×,
is 82× more than the rest of the genome, which was 2 × .
Evaluating overall RSE primer effectiveness in capturing
the MHC, we looked at the depth of coverage at each RSE
primer position (Fig. 6). Out of 500 RSE primers, only 7
were found to produce a depth of coverage of less than
30×. This translates into ≈ 99 % of primers performing at
Fig. 4 Sequencing depth of coverage of the enriched MHC. The RSE enrichment process results in clinical sequencing depth (>30×) for ≈ 97 % of
all enriched bases with >90 % coverage at 50× or greater
Fig. 5 Sequencing depth of coverage map for RSE-extracted MHC region. a MHC sequencing coverage is displayed for the entire enriched 4 Mb
of the PGF MHC region along with 300 kbp of non-targeted sequence on either side. Each qPCR probe assay is marked by a numbered arrow.
b 50 kbp regions around each of three qPCR assays is shown to demonstrate differing levels of coverage. RSE capture primer positions are
marked with a green marker. The red circle shows the approximate depth of coverage at the qPCR probe position. While regions 2 and 5 have
differing average depth of coverage, the qPCR results at the site of capture are very similar (930 vs 1010 copies/μl) which suggest similar amounts
of enrichment that is validated by the sequencing depth of coverage results (130 vs 95). Region 3 shows enhanced depth of coverage and
suggests higher enrichment that is validated by the higher qPCR results (2569 copies/μl). The depth of coverage results correlate well to the qPCR
copy number estimates of the extracted material: higher enrichment = higher depth of coverage
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our target coverage of 30× or better (30× being considered
sufficient for diagnostic applications). Evaluating the
midpoint between RSE primers also validated that the
RSE primer positioning of approximately 8 kbp between
primer sites was sufficient to obtain robust coverage. In
this case, only 16 midpoints were at <30× depth of cover-
age which means that ≈ 97 % of RSE primers were able to
provide adequate (≥30×) depth of coverage across the
entire MHC region. This indicates that the RSE primer
spacing of 8 kbp was successful at delivering the targeted
genomic template across the continuum of the MHC. It
should also be mentioned that the variation of depth of
coverage observed across the 4 Mb of the MHC in Fig. 5a
is most likely reflection of the effectiveness of the different
primers for capturing their respective regions. This is
clearly supported by the variable depth of coverage
observed exactly at each of the primer position shown
in Fig. 6.
Gap-free robustness of capture
From an optimization standpoint, this means that only
16 locations would require further RSE primer design or
development to provide better depth of coverage at these
sites. Considering that only 500 primers are needed to
capture the entire MHC, the need to redesign 16 sites
out of 500 from a first pass primer design is further
evidence of the robustness of the method. From an
overall efficiency standpoint, RSE capture produced an
enrichment factor of about 82.7; less than that seen with
some other technologies. The reasons for this are in part
inherent in the capture of very large fragments: cross-
hybridization between targeted and non-targeted regions
can occur if the targeted genomic segments contain
sequences - such as highly repetitive elements - that are
also present on other, non-targeted fragments, unless
suppressed by blocking such sites during the extraction.
Shearing the DNA before capture can reduce the amount
Table 2 qPCR correlation to sequencing coverage
qPCR Probe Position within MHC Corr. Coef Corr. Coef
30362055 31417450 31682240 32016911 32935499 1&2 2&3
(1) non-Amped 1565 930 2569 1227 1010
0.94
(2) WGA 4,201,954 3,312,705 12,750,000 5,974,923 2,337,060
0.97
(3) Coverage Depth 166 130 372 253 95
(1) & (2) results are copies of target per ul of extracted material
Fig. 6 Average depth of coverage at the site of capture and midpoint between capture primers. Average depth of coverage was calculated
across all bases underlying each RSE capture primer position. Black diamonds represent the average depth of coverage at the RSE primer position
while open circles represent the average depth of coverage at the midpoint between adjacent RSE primers. Out of 500 RSE primers, only 7 were
at a depth of coverage of <30× at the RSE capture site (≈ 99 % produced 30× coverage or better) while only 16 midpoints between RSE primers
were at a depth of <30× (≈ 97 % of the midpoints were 30× and above)
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of off-target DNA, however this also decreases the
available linkage distance. An alternative way to reduce off
target material is the use of freshly prepared DNA.
Regardless, however, sufficient enrichment for the region
of interest is obtained to detect variants accurately.
In a recent publication whereby the MHC (4.9 Mb) of
PGF was targeted using a Roche-Nimblegen array [15],
the authors acknowledge the limitation of their targeting
approach, as well as of most other methods, stating that
they were unable to fully cover long, repeated regions
and present 100 % coverage of the MHC region. They
were able to cover about 94 % of the MHC, as compared
to the 99.4 % covered by the RSE at a depth of ≥10×.
They recognize that capturing fragments of 5 kbp or
even longer will have a beneficial effect in coverage, par-
ticularly for regions that are long and highly repetitive.
While current technologies with closely spaced cap-
ture oligos suffer from any underlying variability across
the targeted area, RSE primers are designed every 8-10
kbp. As such they can be located within regions of lower
variability in order to avoid any placement in areas of
genomic complexity. This strategy does not completely
rule out any instances of variability at a chosen primer
hybridization site, but it does provide for the greatest
likelihood that any given capture primer is unaffected by
every known genetic variance. In addition, because of
the very short length of RSE primers compared to that
of other types of capture probes (or “baits”), the RSE
primers can reliably and redundantly be placed through-
out even the most inaccessible regions of highly complex
genomes (such as certain plant and animal genomes)
that typically get completely repeat-masked and leave no
adequately spaced unique sequence regions for the bind-
ing of larger capture probes (“baits”). Furthermore the
Roche-Nimblegen array, mentioned earlier [15] for the
capture of the MHC, needs to include probes that cover
85 % of the total bases of the MHC, which is close to
3.4Mbp, while the 500 primers used for the RSE cover
about 0.25 % of the MHC, which is about 10kbp. There-
fore there is a substantive lower number of oligos that
need to be synthesized for the RSE vs the array capture
method by Roche-Nimblegen.
Universal capture sets for highly variable target regions
Our current experience is that, irrespectively of the
complexity of a genomic region, a single standard set of
primers can be designed and is able to successfully
capture the full extent of complex targeted regions of
many different DNA samples (the 4 Mb of the MHC
from five other homozygous cell lines have been suc-
cessfully captured and sequenced; data not shown). This
is possible because, in contrast to other capture method-
ologies, the number of primers to target a particular
region is over 100 fold reduced and we can therefore
create a near-universal primer set for any given region
that contains at least a number of conserved reference
points; even when the target region is otherwise highly
polymorphic or contains unexpected, unknown sequence
or repeat elements.
In the event that some of the designed primers do turn
out to be ineffective in terms of capturing a particular
region because of local variation, the nature of the
method is such that such primers can easily be rede-
signed and included in the mixture of primers that
capture the entire region of interest, without the need
to change or re-synthesize any of the others. The
capture primers are only about 20-25 nucleotides
long, which means that the vast majority of the tar-
geted region never directly comes in contact with any
capture primers. This is important because it makes
the enrichment nearly immune to pull-down failure
and allelic dropout in the case of genomic variations
that have not been or could not be anticipated in the
capture primer design.
In comparison, other methods may require capture
probe/primer sets with a combined coverage of the
probe/primer that sums up to more than half the
sequence of a targeted region (85 % in the case of
Roche-Nimblegen array for the MHC [15]). This leads to
a correspondingly high risk of pull-down failure when
mutations occur in the region because any stretches of
unknown or unexpected sequence within the target
region will likely be missed since no capture primers
were designed for them. It is important to note at this
point that in order to enable streamlined applications in
medical diagnostics and theranostics, a single set of
reliable capture primers is essential. Designing a single
set of reliable capture primers can also be a valuable
asset for navigating around other complex and variable
sequences that are not fully referenced yet, such as
oncology specimens and many plant or animal genomes
that are of scientific and economic interest.
Variant analysis and sanger validation
From a sequencing perspective, the ultimate goal is to
provide high depth of coverage across an entire gen-
omic region to promote accurate alignment and variant
calling, including sections of the targeted region that
may contain unexpected or novel sequence variants.
With an average depth of coverage of 164× for all 4 Mb
of the targeted MHC, the RSE extraction produces very
high depth of coverage. The greatest advantage of RSE
is that the depth of coverage is maintained contiguously
for almost all bases across the entire region - not
merely for exonic regions – and therefore includes
important elements such as regulatory and promoter
regions that may be key to explaining phenotypes
associated with diseases.
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The sequencing results were then analyzed to detect
variations between the reference genome and the PGF
sequencing data. Out of 4 million bases sequenced, a
total of 430 variants were found with 409 being single
nucleotide substitutions and 21 being in/dels. This
defines a variant load of ≈ 1 variant per 9302 bp for the
targeted region. Among unique sequences, 102 variants
were found corresponding to a variant load of 1 in
18,585 bp. Raw variants were filtered to include only
those variants with a coverage depth greater than
20× and a QUAL score greater than 30, leaving 92 identi-
fied single nucleotide substitutions and 10 indels.
With 20× depth of coverage, the alignment of the
MHC region was sufficiently accurate to detect a sur-
prising number of variations in an otherwise “stable” cell
line. In comparing the discovered variants to the refer-
ence genome, it was important to discern how many of
these variants were reference errors and how many were
NGS errors. The NGS data was therefore validated by
performing Sanger sequencing on a subset of variants
that were located within unique sequences. This analysis
included 83 single nucleotide substitutions and 3 in/dels.
Table 3 shows the distribution of variant data in light of
Sanger validation of the NGS results. Of the 86 variants
tested by Sanger sequencing, 61 were located directly
within gene regions and included 3 in/dels. Of these
variants, 8 were single nucleotide substitutions within
exons and 50 were within introns. Twenty-five total vari-
ants found were single nucleotide substitutions within
intergenic regions. In comparing NGS sequencing re-
sults to the Sanger validation sequencing, we found that
a total of 50 variants were both detected by the NGS se-
quencing and confirmed by Sanger sequencing. Thirty-
five of these variants are clearly reference sequence
errors since the single nucleotide substitutions represent
a homozygous (a/a) to homozygous (b/b) allele switch
(an unlikely biological scenario in a homozygous cell
line). Fifteen of these variants in the PGF cell line grown
in our lab were found to be heterozygous (homozygous
reference, heterozygous NGS/Sanger sequencing results)
which suggests possible de novo polymorphic changes.
Additionally, 36 variants found by NGS sequencing at
more than 30× depth of coverage were not supported by
Sanger sequencing (for the complete variant table, see
Additional file 1: Table S4). In these cases, the Sanger
results supported the reference genome, suggesting that
these errors may be attributed to the NGS workflow.
Further systematic investigation into the potential cause
of these NGS related errors (data not shown) reveals a
number of different reasons, including base modifications
introduced during WGA or library preparation and Illu-
mina sequencing errors located towards the end of the
sequencing reads or within low complexity regions (high
GC content, homopolymer stretches, di and tri-nucleotide
repeats etc.). Although the sequencing limitations of the
Illumina platform, particularly within low complexity re-
gions have been previously described [37, 38], recent
improvements and adaptations of NGS protocols have
demonstrated promising results in sequencing difficult
templates [39] and warrant further investigation within
our particular application.
RSE resolves erroneous classification of MHC variants
Two additional variants were caused by read misalign-
ment from a segmental duplication (Additional file 1:
Figure S1) (data not included in Table 3). In this case,
read alignment identified a “polymorphism” between the
two copies of a known segmental duplication. The erro-
neous classification of this paralogous sequence variant
(PSV) as a SNP in the reference sequence was caused by
improper segregation of the reads due to an error in the
reference sequence located at one of the duplications:
The reference error incorrectly identified the central
portion of the duplications as being identical, when in
reality there was a single base difference between them.
The reference error was confirmed by Sanger sequen-
cing and upon editing of the reference sequence, the
NGS reads were properly aligned, eliminating the two
identified discrepancies (see Additional file 1: Figure S1).
A large portion of the NGS errors have known causes,
but clearly premature assumptions should not be made
when examining variant tables even when the depth of
coverage is very high. We strongly suggest that critical
variants be further examined at the bam-file level to
determine the likelihood of an NGS error.
Detecting variation within the HLA genes
Considering that the accuracy of the overall unique
MHC sequences was 1 variant in every 18,585 bases and
that cumulatively the number of bases for the 6 HLA
Table 3 Sanger validation of identified NGS variants
Type of variants Sanger agrees with NGS Sanger agrees with reference Total
61 Sanger Validated Variants (Gene Regions) Exonic 4 4 8
Intronic 28 22 50
Insertions/deletions 3 3
25 Sanger Validated Variants (Intergenic) Mismatches 15 10 25
50 36 86
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genes is ≈ 38.4 kbp, it would be expected to have no more
than 2 variants in the 6 HLA sequences. However, our
HLA typing results were found to be concordant with
those alleles previously reported by the MHC haplotype
project [33] for the homozygous cell line, PGF, with 100 %
sequence identity between our consensus sequence for
each locus and the reported allele for each locus consid-
ered. The exact typing determined by our method was
HLA-A*03:01:01:01, B*07:02:01, C*07:02:01:03, DRB1*15:
01:01:01, DQB1*06:02:01, DPB1*04:01:01:01.
Methodological challenges
Due to the nature of its underlying principle, RSE has
distinct advantages over current techniques as well as
restrictions that can limit its effectiveness depending on
the application. For example, the ability to capture DNA
segments that are at least an order of magnitude larger
than those isolated with other methods comes with a
lower overall capture efficiency per locus compared to
short-fragment pull-down methods. For most RSE
captures, the maximum amount of material extracted at
any targeted region is generally less than 30 % and
usually around 10 % of the total DNA captured (Table 1:
reads mapped to targeted region/reads mapped to whole
genome = 10.34 %), again dependent on the length of
the DNA template before RSE and the target DNA’s
degree of entanglement with other strands during
isolation by RSE.
Hybridization of primers to non-targeted sites and the
addition of the capture moiety, biotin, via primer
extension-based nucleotide addition can result in ran-
dom accumulation of off-target material. DNA quality -
i.e. primarily age, the method used for its extraction
from blood/tissue/cells, and conditions for its storage
and handling - play a crucial role here and can be a
major cause for off-target material accumulation. Exten-
sive heating also creates DNA damage. For certain appli-
cations it may therefore be advisable to perform an
alkaline denaturation instead of one by heat.
Lastly, due to the large DNA segments captured by
RSE, it also isolates any repeat regions that are located
within 10-20 kbp of a target site. If present in high copy
numbers, DNA fragments deriving from these segments
can result in unintended self-priming events during any
required subsequent whole genome amplification
(WGA) step, which may disproportionately increase the
amount of these sequences if the amplification time is
allowed to be long. While there is no indication in the
depth of coverage data that this was a significant prob-
lem adversely affecting our sequencing results, it is
known that excessive WGA times can lead to bias in
template over-representation. We therefore recommend
limiting any WGA to 1-2 h (for the Qiagen REPLI-g
Mini kit) unless forced to work with very small amounts
of input DNA for RSE. Recent advances in NGS library
preparation protocols have drastically reduced the
amount of input DNA needed (< 20-50 ng), which obvi-
ates the need to perform the WGA step at all provided
that sufficient amounts of genomic DNA template are
available for RSE.
The main advantage of RSE is its ability to specifically
capture and provide unambiguous sequence data even for
DNA sections that are embedded in highly repetitive,
complex or unknown regions. The corresponding amount
of off-target material still does present challenges to the
sequence alignment process and limits the degree of sam-
ple multiplexing per NGS run, but it can be controlled to
some degree through the steps listed above. As seen in the
sequencing results shown here, the number of reads that
aligned to the targeted MHC region is ≈ 10 % of the total
number of reads that map to the genome (Table 1). The
amount of off-target material is largely spread evenly
across the entire genome with very low coverage. This
reduces its impact and allows for high quality sequencing
and accurate variant detection for large, contiguous
genomic regions of interest.
Conclusions
Region specific extraction is a genomic targeting method
with distinct advantages over other, currently employed
targeting approaches. By capturing very long (≈ 20 kbp
in this study), overlapping DNA segments directly from
a sample of genomic DNA, RSE can isolate an entire
contiguous target region, including exonic, intronic and
intergenic regions. As such it provides the framework
for the reliable characterization of any genomic region,
regardless of its complexity and variability. With an
appropriate sequencing technology that can characterize
long fragments (i.e. Pacific BioSciences, Oxford Nano-
pore), RSE can also provide haplotype phase informa-
tion, thereby setting the stage for accurate de novo
assembly of targeted genomic regions such as the MHC.
RSE was able to deliver adequate coverage (99.937 %)
and impressive accuracy (99.99 %-1 variant in every
9302 bases) throughout a highly complex target region.
While our analysis of short Illumina reads, derived from
the homozygous cell line PGF, has facilitated the com-
prehensive characterization of the PGF MHC through
reference-guided read mapping to the corresponding
MHC haplotype, RSE is uniquely positioned to charac-
terizing the inherent sequence complexity of the MHC
derived from a heterozygous sample. This could be
accomplished via sequencing platforms that generate
long reads which can be used to phase long stretches of
repeat sequence elements and structural variations
present throughout the MHC of a heterozygous sample.
Towards this end, our lab has demonstrated the utility
of RSE to generate long read sequencing templates from
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the targeted MHC capture of the homozygous cell lines
PGF and COX, and subsequent PacBio sequencing. Our
initial results produce PacBio sequencing reads with an
average length of ≈ 4.5 kbp and very encouraging de novo
assembly results (manuscript in preparation), suggesting
that haplotype resolved de novo assembly of heterozy-
gous MHC samples is feasible.
Methods
Genomic DNA preparation
The PGF and GM 12248 (CEPH collection) cell lines
were obtained from Coriell Cell Repositories. Cells were
cultured overnight at 37 °C, 5 % CO2. On the next day,
cells were split into two 75 cm2 culture flasks and
cultured in 10 ml of RPMI1640 containing 10 % Fetal
Calf Serum at 37 °C, 5 % CO2. After obtaining 2 × 10
7
cells per flask, gDNA was extracted using a Blood & Cell
Culture DNA Midi Kit (Qiagen, Cat# 13343).
Whole genome amplification
The enriched samples were amplified with REPLI-g Midi
Kit (Qiagen Cat.# 150043) according to manufacturer’s
protocol using 5 μl of RSE template and incubating at
30 °C for 16 h followed by inactivation of the enzyme at
65 °C for 3 min. Residual primers and dNTPs were
deactivated with ExoSAP-IT (Affymetrix, Cat.# 78201
1 μl) according to the manufacturer’s protocol (http://
media.affymetrix.com/support/technical/usb/brochure/
ExoSAP-IT_Brochure.pdf ).
RSE capture primer design
The design of RSE primers used for the capture of tar-
geted regions was performed using a custom designed
software program called RSE Antholigo (available via
http://antholigo.chop.edu/dgdweb/oligo/home.html). It uti-
lizes and integrates tools and databases to automatically
generate primer sets that satisfy several user-defined
criteria at predefined genomic intervals. It accesses a
local installation of the UCSC database and human
genome sequence library downloaded from UCSC
Genome Browser to retrieve DNA sequences that are
masked for repeat regions and SNPs. A genomic re-
gion of interest is parsed into smaller regions in which
the primers are designed approximately equidistant to
each other based upon user settings (currently, the
primers are 6-10 kbp apart). It then uses the primer
design software Primer3 [40] to design the primers
based on user-defined criteria including GC content,
melting temperature and length. After primers are
chosen, homology between selected primers and the
rest of the genome is checked with BLAT [41].
The program targets conserved sequence across the
region of interest. The RSE capture primers had a melt-
ing temperature of approximately 58 °C and GC content
of 50 % (+/-10). Antholigo uses proprietary software
UNAFold [42] that performs a pair-wise assessment of
all primers to ensure minimal primer dimer formation
and minimal hairpin formation. In this experiment, 500
capture primers were designed to target the entire 4
Mbp of the MHC (HG19 coordinates chr6:29618227-
33618227) at an average spacing of ≈ 8 kbp and a target to
primer sequence coverage ratio of > 300 (see Additional
file 1: Table S1 for the list of primers and supporting infor-
mation). The primers were synthesized by IDT (Integrated
DNA Technologies), (Coralville, IA) and provided in their
“Lab Ready” format, pre-diluted to 100 μM. Primers
were then combined (in water) to an equimolar ratio
of all 500 primers.
Region Specific Extraction (RSE)
Each 30 μl RSE reaction contained approximately 550 ng
genomic DNA, 5 μM region specific primer mixture, H-
Buffer containing polymerase, dNTPs and biotinylated
dNTPs (Generation Biotech, Prod.# 720; www.genera-
tionbiotech.com) and DNAse-free water. Extractions
were placed on a heat block with a heated lid (SciGene
Hybex™; www.scigene.com/details.php?pid=1180) to de-
nature the DNA at 95 °C for 7.5 min. The samples were
then transferred to a BioRobot EZ1 (Qiagen). An auto-
mated protocol completes a 20 min incubation at 64 °C
during which the region specific primers anneal and are
enzymatically extended, incorporating a mix of un-
modified and biotinylated dNTPs. The targeted genomic
DNA was captured by incubating with 60 μl of
streptavidin-coated magnetic microparticles (Generation
Biotech, Prod.# 710) at room temperature on the EZ1
following GB protocol. The EZ1 protocol washes the mi-
croparticles containing the captured DNA to remove
non-targeted DNA. The particles carrying the targeted
DNA are then collected and resuspended in 50 μl
Qiagen EB buffer on the EZ1. The captured DNA is then
removed from the magnetic particles by heating the
solution at 80 °C for 15 min and magnetically collect-
ing the particles. The target DNA is retained in the
supernatant.
Capture efficiency assessment
The capture efficiency at different distances from the
primer hybridization site was assessed using, seven loci
(CLEC16A, EGFR, BRCA2, KCNE1, NOS3, KCNJ2 and
CETP) all outside the MHC, by qPCR (quantitative
PCR) using RSE captured material from the GM 12248
DNA sample. For each 25 μl reaction, 10 μl of enriched
DNA sample were combined with 1× Qiagen Quantitect
Probe PCR master mix (Cat. # 204345), 0.4 μM each of
forward and reverse primers (IDT) and 0.2 μM probe
(IDT). See Additional file 1: Table S2 for a list of qPCR
primers and probes.
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For the five qPCR assays used to quantify the PGF
MHC extraction (Additional file 1: Table S2, MHC-1,
MHC-2, MHC-3, MHC-4, MHC-5), 10 μl of sample
were combined with 1× Qiagen Quantitect Probe PCR
master mix (Cat. # 204345), 0.4 μM each of forward and
reverse primers (IDT) and 0.2 μM probe (IDT) for
assays in target region. Six 1:3 serially diluted GM12248
or PGF genomic DNA standards were run in duplicate
for each locus as well as a single negative control. Forty
cycles of (95 °C for 15 s, 60 °C for 1 min) were run after
the initial denaturation at 95 °C for 15 min. Fluorescence
was collected at 60 °C. The selection of sites for the
design of the qPCR assays is made accounting for the
sequencing characteristics of a particular region and its
surrounding context, such that each assay will have
reasonable chances to work. Depending on the size of
the targeted region, multiple qPCR assays should be
designed for both target and non-targeted regions for an
accurate estimation of enrichment and of the corre-
sponding depth of coverage that can be achieved after
sequencing (See Additional file 1: Table S2 for a list of
qPCR primers and probes).
Agilent custom array comparative genomic hybridization
Comparative Genomic Hybridization was used to assess
optimal spacing of primers. Four loci (EGFR, BRCA2,
KCNJ2 and CLEC2) were targeted with 46 primers (See
Additional file 1: Table S5 for the complete list of
primers used to capture the four regions) using genomic
DNA from GM 12248 cell line. DNA was prepared using
standard automated bead-based methods from Qiagen.
This process generally produces genomic fragments in
the 20–40 kbp range. A custom Agilent 8 × 15 K Agilent
Comparative Genome Hybridization microarray (CGH)
was designed using Agilent’s online tools (https://earray.-
chem.agilent.com/suredesign) and ordered using their
standard custom array process. The array was used ac-
cording to the manufacturer’s protocol, ver 5.0. Briefly,
genomic DNA and whole genome amplified RSE ex-
tracted material was restriction digested with Alu I and
Rsa I. The digested material was then labeled with Cy3
or Cy5 using the random priming process of the manu-
facturer. Labeled samples were then washed, filtered
and checked for expected yields. 8 μl of each labeled
sample was then prepared for hybridization by placing
in blocking buffer (Cot-1, Agilent 10× blocking buffer
and 2× hyb buffer), heated to 95 °C for 3 min, then
placed in a water bath at 37 °C for 30 min. The custom
array was prepared as per instructions. Sample was
hybridized to the array at 65 °C for 24 h. The hyb
cassette was opened and the array washed per instruc-
tions. The array was scanned at 5 μm resolution. Raw
data was analyzed with the Agilent Feature Extraction
software version 9.5 using default parameters.
Enrichment determination
Targeted enrichment values were calculated from Illumina
sequencing read data using the formula from Gupta,
et al. [43]:
number of reads that map to the target regionð Þ
total number of readsð Þ
target region sizeð Þ
haploid genome sizeð Þ
Enrichment was estimated based on a haploid genome
size of 3.2 Gb for the cell line used and on the data
shown in Table 1. The enrichment was: (6,951,692/
67,257,141)/(4,000,000/3.2*10^9) = 82.7.
Illumina GAIIx sequencing
Five micrograms of enriched, amplified material were
used as input for preparation of the sequencing library.
The library was prepared for sequencing using the
Illumina Paired-End DNA Sample Prep Kit (Cat. # PE-
102-1001), according to the manufacturer’s protocol.
Sequencing was performed using an Illumina Genome
Analyzer IIx, 2 × 125 base paired-end chemistry. Raw
data (fastq) files have been made publicly available and
are accessible on the NCBI SRA website (SRA accession:
SRP075425).
Sanger sequencing
To validate variant calls, genomic or whole genome ampli-
fied DNA was used. PCR primers for each variant were de-
signed manually using the IDT website (www.idtdna.com).
The full list of PCR primers is provided in Additional file 1:
Table S3.
To set up each PCR reaction, 150 ng of gDNA or
whole genome amplified DNA was combined with 10×
PCR buffer (Qiagen), 10 mM dNTP mix (Life Technolo-
gies, Cat. # 18427088), 5U/μl HotStar Taq DNA Poly-
merase (Qiagen, Cat. # 203203), 5 μM each of forward
and reverse primers and water. The thermocycling
protocol was 10 min at 94 °C for the initial denaturation
followed by 37 cycles of 30 s at 94 °C, 30 s at 53 °C or
57 °C, 30 s at 72 °C and a final extension for 5 min at
72 °C.1 After PCR, 2 % gel electrophoresis was per-
formed to validate amplification. Then each amplicon
was purified with 4 μl of ExoSAP-IT (Affymetrix, Cat. #
78201 1 μl) by incubation for 45 min at 37 °C, followed
by inactivation of the enzyme for 15 min at 80 °C.
Sanger sequencing was performed using the same
primers, which were used for PCR amplification. Two μl
of each amplicon were combined with 0.5 μl of 3.2 μM
of each forward or reverse sequencing primer, 1.5 μl Big
Dye 5× sequencing buffer, 1 μl Big Dye Terminator v 1.1
(Life Technologies, cat#4336701) and 5 μl water. The
cycle sequencing protocol was 10 s at 96 °C followed by
25 cycles of 10 s at 96 °C, 10 s at 50 °C and 2 min at
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60 °C. Reactions were precipitated with 2 μl NaOAc/
EDTA buffer, followed by a wash using absolute ethanol
and a second wash using 80 % ethanol and resuspended
in 15 μl HiDi-formamide. The raw data was analyzed
with Sequencing Analysis software, version 5.2 (Life
Technologies/Applied Biosystems).
Sequence alignment & variant detection
PGF sequencing data was generated from 125 bp paired-
end reads generated on the Illumina GAIIx sequencing
platform. The paired-end reads were quality trimmed
(minimum PHRED score of 30) using sickle version 1.010
(https://github.com/najoshi/sickle). Quality trimmed reads
were aligned to the reference genome (HG19) using BWA
version 0.6.2-r126 with default parameters [44]. After
alignment, variant calling was performed following GATK
v3 best practices with recommended parameters for
accurate and efficient variant calls [45] (GATK version
1.6-2-gc2b74ec and Picard version 1.57). The only step
not applied was the removal of duplicates since the target
(4 Mb of the MHC) was relatively small compared to the
whole human genome.
Sequence variation within HLA loci
Reads mapped to the reference genome (HG19) were used
to generate a consensus sequence for all HLA loci consid-
ered for typing (HLA-A, HLA-B, HLA-C, HLA-DRB1,
HLA-DQB1, HLA-DPB1). For each locus, a consensus
sequence was generated from the set of mapped reads
using Samtools [46]. The consensus sequence obtained
from each locus was then aligned pairwise against each
fully characterized allele within the IMGT database (Im-
MunoGeneTics; www.ebi.ac.uk/ipd/imgt/hla) for each re-
spective locus using the Needleman-Wunsch algorithm as
implemented within MATLAB. The highest alignment
score was then used to call the allele for each locus and
the percent sequence identity between a given consensus
sequence and assigned allele for the particular locus in
question was also calculated.
Endnotes
1Different temperatures were used depending on Tm
of the primer pair (see Additional file 1)
Additional file
Additional file 1: Table S1. 500 RSE capture primers designed using
Antholigo. The genomic position (HG19) of the primers as well as the
sequence and spacing between primers is provided in addition to other
design criteria metrics including deltaG, Tm, and GC%. Table S2: List of
qPCR primers and probe sequences designed to amplify regions within
several genes (ACTB, EGFR, CLEC16A, BRCA2, CETP, KCNJ2, KCNE1, NOS3) as
well as five MHC locations (MHC-1, MHC-2, MHC-3, MHC-4 and MHC-5 as
indicated by arrows in Fig. 5a). Table S3: PCR primer location and
sequences designed to validate high-confidence variant calls from
NGS results. Table S4: Results from Sanger validation of high confidence
variants identified by NGS. Table S5: 46 RSE primers designed to capture
the four genes (~700 kb in total) in order to examine the effect of RSE
primer spacing on capture efficiency (Fig. 3). Figure S1: Read segregation
problems caused by reference sequence error in regional duplication. A
2.5 kb duplication (a) within the MHC presented difficulties during the
alignment of reads to this region. Reads at the beginning and ends of the
duplicated regions segregated cleanly due to polymorphic differences
between the duplications. But reads aligning to the middle of the duplication
identified a variant position (marked by an *) (b). Sanger sequencing of this
region identified that the reference sequence incorrectly identified the * base
in the second duplication as a T, when it was actually a C, creating a false
variant position. After correcting the reference sequence (c), the central reads
segregated correctly and the false variant was eliminated. (PDF 1372 kb)
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